Recorded Groups

European Prostate Cancer Virtual Support Group, March 18, 2026: Is 5 years on enzalutamide without a change too long?

Active Surveillance Prostate Cancer Video Chat, March 11th, 2026

Low/Intermediate PCa, Video Chat, March 9, 2026: The value of connecting with other AnCan peers to compare doctor recommendations and treatment experiences.

Hi-Risk/Recurrent/Advanced PrCa Video Chat, 3/2/26: Two men recur from low levels, one younger, while a much younger man is denovo metastatic

Veterans Video Chat, March 3, 2026: How to file a supplemental claim and preserve your original intent to file date.

Low/Intermediate PCa Video Chat, February 23, 2026: Addressing the unusual: Low PSA with high-grade prostate cancer

Hi-Risk/Recurrent/Advanced PrCa Video Chat, 3/2/26: AnCan’r considering AMG509 STEAP T-Cell engager; does IDC-P make you high risk?

Learn from AnCan’s Emperors of Estradiol… video chat and discussion – PRICELESS peer discussion about using Estradiol (E2) for prostate cancer management

Active Surveillance Prostate Cancer Video Chat, February 25th, 2026

Hi-Risk/Recurrent/Advanced PrCa Video Chat, 2/24/26: Switching hormone therapy drugs and for how long is the flavor of the day.

Hi-Risk/Recurrent/Advanced PrCa Video Chat, 2/16/26: Pros & Cons of Estradiol (E2) as primary and complementary ADT… & mustard!

Veterans Video Chat, February 17, 2026: Making end-of-life arrangements with Veterans Affairs (VA)